Personal information

Other IDs

Scopus Author ID: 55206329100

Activities

Collapse all

Employment (1)

IRCCS Humanitas Research Hospital: Rozzano, IT

Biologo (IRCCS Humanitas Research Hospital)
Employment
Source: Self-asserted source
chiara milanesi

Works (15)

CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature

Leukemia & Lymphoma
2023-07-29 | Journal article
DOI: 10.1080/10428194.2023.2227750
Contributors: Vincenzo Guastafierro; Marta Ubezio; Nicla Manes; Chiara Milanesi; Matteo Della Porta; Arturo Bonometti
Source: check_circle
Crossref

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System

Leukemia
2017 | Journal article
DOI: 10.1038/leu.2017.88
EID:

2-s2.0-85017158916
Contributors: della Porta, M.G.; Jackson, C.H.; Alessandrino, E.P.; Rossi, M.; Bacigalupo, A.; van Lint, M.T.; Bernardi, M.; Allione, B.; Bosi, A.; Guidi, S. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation

Journal of Clinical Oncology
2016 | Journal article
DOI: 10.1200/JCO.2016.67.3616
EID:

2-s2.0-84992425369
Contributors: Della Porta, M.G.; Gallì, A.; Bacigalupo, A.; Zibellini, S.; Bernardi, M.; Rizzo, E.; Allione, B.; Van Lint, M.T.; Pioltelli, P.; Marenco, P. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms

Leukemia
2016 | Journal article
DOI: 10.1038/leu.2015.277
EID:

2-s2.0-84959370553
Contributors: Pietra, D.; Rumi, E.; Ferretti, V.V.; Di Buduo, C.A.; Milanesi, C.; Cavalloni, C.; Sant'Antonio, E.; Abbonante, V.; Moccia, F.; Casetti, I.C. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

LNK mutations in familial myeloproliferative neoplasms

Blood
2016 | Journal article
DOI: 10.1182/blood-2016-04-711150
EID:

2-s2.0-85015186867
Contributors: Rumi, E.; Harutyunyan, A.S.; Pietra, D.; Feenstra, J.D.M.; Cavalloni, C.; Roncoroni, E.; Casetti, I.; Bellini, M.; Milanesi, C.; Renna, M.C. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Tie2 expressing monocytes in the spleen of patients with primary myelofibrosis

PLoS ONE
2016 | Journal article
DOI: 10.1371/journal.pone.0156990
EID:

2-s2.0-84976271582
Contributors: Campanelli, R.; Fois, G.; Catarsi, P.; Poletto, V.; Villani, L.; Erba, B.G.; Maddaluno, L.; Jemos, B.; Salmoiraghi, S.; Guglielmelli, P. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms

Blood
2016 | Journal article
DOI: 10.1182/blood-2015-07-661835
EID:

2-s2.0-84958213572
Contributors: Milosevic Feenstra, J.D.; Nivarthi, H.; Gisslinger, H.; Leroy, E.; Rumi, E.; Chachoua, I.; Bagienski, K.; Kubesova, B.; Pietra, D.; Gisslinger, B. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Efficacy of ruxolitinib in myeloid neoplasms with PCM1-JAK2 fusion gene

Annals of Hematology
2015 | Journal article
DOI: 10.1007/s00277-015-2451-7
EID:

2-s2.0-84941994977
Contributors: Rumi, E.; Milosevic, J.D.; Selleslag, D.; Casetti, I.; Lierman, E.; Pietra, D.; Cavalloni, C.; Bellini, M.; Milanesi, C.; Dambruoso, I. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia

Haematologica
2015 | Journal article
DOI: 10.3324/haematol.2015.131458
EID:

2-s2.0-84946219936
Contributors: Rumi, E.; Bertozzi, I.; Casetti, I.C.; Roncoroni, E.; Cavalloni, C.; Bellini, M.; Sant’Antonio, E.; Gotti, M.; Ferretti, V.V.; Milanesi, C. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis

Blood
2014 | Journal article
DOI: 10.1182/blood-2014-01-550434
EID:

2-s2.0-84901777448
Contributors: Rumi, E.; Harutyunyan, A.S.; Pietra, D.; Milosevic, J.D.; Casetti, I.C.; Bellini, M.; Them, N.C.C.; Cavalloni, C.; Ferretti, V.V.; Milanesi, C. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis

Blood
2014 | Journal article
DOI: 10.1182/blood-2014-05-578435
EID:

2-s2.0-84905990634
Contributors: Rumi, E.; Pietra, D.; Pascutto, C.; Guglielmelli, P.; Martínez-Trillos, A.; Casetti, I.; Colomer, D.; Pieri, L.; Pratcorona, M.; Rotunno, G. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

Blood
2014 | Journal article
DOI: 10.1182/blood-2013-11-539098
EID:

2-s2.0-84897517940
Contributors: Rumi, E.; Pietra, D.; Ferretti, V.; Klampfl, T.; Harutyunyan, A.S.; Milosevic, J.D.; Them, N.C.C.; Berg, T.; Elena, C.; Casetti, I.C. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms

Blood
2013 | Journal article
DOI: 10.1182/blood-2013-02-486050
EID:

2-s2.0-84880595307
Contributors: Rumi, E.; Pietra, D.; Guglielmelli, P.; Bordoni, R.; Casetti, I.; Milanesi, C.; Sant’Antonio, E.; Ferretti, V.; Pancrazzi, A.; Rotunno, G. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

Somatic mutations of calreticulin in myeloproliferative neoplasms

New England Journal of Medicine
2013 | Journal article
DOI: 10.1056/NEJMoa1311347
EID:

2-s2.0-84890372480
Contributors: Klampfl, T.; Gisslinger, H.; Harutyunyan, A.S.; Nivarthi, H.; Rumi, E.; Milosevic, J.D.; Them, N.C.C.; Berg, T.; Gisslinger, B.; Pietra, D. et al.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier

JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms

American Journal of Hematology
2012 | Journal article
DOI: 10.1002/ajh.23229
EID:

2-s2.0-84862536815
Contributors: Pietra, D.; Casetti, I.; Da Vià, M.C.; Elena, C.; Milanesi, C.; Rumi, E.
Source: Self-asserted source
chiara milanesi via Scopus - Elsevier
How many people are using ORCID?